Randomized control trial of effect of apitherapy to prevent salivary gland disorder during I-131 ablation in patients with differentiated thyroid cancer.

Randomized control trial of effect of apitherapy to prevent salivary gland disorder during I-131 ablation in patients with differentiated thyroid cancer. - Effect of apitherapy to prevent salivary gland disorder during I-131 ablation.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021740

Enrollment

100

Registered

2016-04-07

Start date

2016-05-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid cancer

Interventions

Apitherapy using honey control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)a patient who underwent total thyroidectomy for thyroid cancer 2)submitted written consent as a participant

Exclusion criteria

Exclusion criteria: 1)a patient with cognitive impairment 2)pregnant female and feeding female 3) a patient with diabetes mellitus 4)when medical staff determine that treatment can not be properly carried out

Design outcomes

Primary

Measure	Time frame
salivary gland disorder	—

Countries

Japan

Contacts

Public ContactMichihiro Nakayama

Asahikawa Medical University Department of Radiology

m-naka@asahikawa-med.ac.jp0166-68-2572

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026